PGP and breast carcinoma: Similar activity was observed for the flavonoid glabridin in breast cancer cell lines, MDA-MB-231/MDR1 resistant (with overexpression of P-gp), and in MCF-7/ADR cells (with overexpression of P-gp and MRP2).